Sign inJoin waitlistJoin the waitlist

Nam Quoc Bui

Founding Editor-in-Chief

Credentials: · · · ·

History

Stanford Cancer Institute
Present
Stanford University School of Medicine
Present

UCSD
Until 2017
Stanford University
Until 2014
University of Texas Southwestern Medical School Registrar
2011
Stanford University
2007

Research

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
New England Journal of Medicine · 2023 · 219 citations
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers
Nature Communications · 2019 · 86 citations
Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
Molecular Cancer Therapeutics · 2017 · 77 citations

Kristen Ganjoo
32 papers
Gregory Charville
13 papers
Maggie Zhou
13 papers · 13 as a resident
Minggui Pan
9 papers
Stefano Testa
7 papers · 7 as a resident
David Mohler
6 papers
Robert Steffner
5 papers
SC
Sant Chawla
5 papers
Shivaani Kummar
5 papers
DW
David Wang
4 papers
Everett Moding
4 papers
Steven Attia
4 papers

Clinical trials

Study of Cryoablation and Nirogacestat for Desmoid Tumor
Principal investigator · Recruiting · Phase 2
Nam Bui
2023–2028
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2032